Ctrl K
Turn Therapeutics Inc. (TTRX) quarterly cash flow statement — complete operating, investing & financing history
Turn Therapeutics Inc. (TTRX) cash flow statement — 3-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|
| Cash from Operations | -923.36K | -1.63M | -1.18M | -588.61K | -499.97K |
| Operating CF Margin % | - | - | - | - | - |
| Operating CF Growth % | -84.69% | - | - | - | - |
| Net Income | -5.85M | -970.97K | 279.07K | -1.9M | -1.24M |
| Depreciation & Amortization | 14.53K | 14.45K | 14.15K | 13.68K | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.52M | 60.92K | -2.2M | 39.38K | 61.16K |
| Working Capital Changes | 394.84K | -737.2K | 732.59K | 1.26M | 679.29K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 290.49K | -613.46K | 664.3K | 1.25M | 370.84K |
| Cash from Investing | -5.8K | -12.23K | -31.44K | -89.79K | -31.75K |
| Capital Expenditures | -5.8K | -12.23K | -31.44K | -89.79K | -31.75K |
| CapEx % of Revenue | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 7.79M | 3.18M | 594.62K | 2.15M |
| Debt Issued (Net) | 0 | 6.72M | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 3.18M | 594.62K | 2.15M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 1.07M | 0 | 0 | 0 |
| Net Change in Cash | -929.16K | 6.14M | 1.97M | -83.79K | 3.19M |
| Free Cash Flow | -923.36K | -1.63M | -1.18M | -588.61K | -499.97K |
| FCF Margin % | - | - | - | - | - |
| FCF Growth % | -84.68% | - | - | - | - |
| FCF per Share | -0.03 | -0.06 | -0.04 | -0.02 | -0.04 |
| FCF Conversion (FCF/Net Income) | 0.16x | 1.68x | -4.21x | 0.31x | 0.40x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |